drugset / Trial / NCT01471119
Sublingual Immunotherapy in Patients With Atopic Dermatitis
Phase 2
Completed
239 enrolled
Zhejiang University
First Affiliated Hospital of Suzhou Medical College · collabHuashan Hospital · collabPeking University Third Hospital · collabTongji Hospital · collabWolwo Bio-pharmaceutical Co. LTD. · collabXinhua Hospital, Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the effect and safety of sublingual Dermatophagoides Farinae Drops in adult patients with atopic dermatitis and allergic sensitization to house dust mites.240 adults age 18 to 60 years with atopic dermatitis(Objective Scoring Atopic Dermatitis, Objective SCORAD from 10 to 40) are going to be enrolled in a randomized,double-blind,placebo-controlled study.Sublingual Dermatophagoides Farinae Drops or placebo is given for 9 months in addition to standard therapy.SCORAD,average anesis interval,rescue medicine and DLQI will be recorded.
Timeline
- Start
- 2011-10
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dermatophagoides Farinae Drops | Unknown | 1 unknown | Other |
| Subject | Dermatophagoides Farinae Drops | Unknown | 2 unknown | Other |
| Subject | Dermatophagoides Farinae Drops | Unknown | 3 unknown | Other |